Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Gloria Lombardo"'
Autor:
Roberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, Istvan Bartha, Francesco Muoio, Katja Culap, Nicole Sprugasci, Gloria Lombardo, Christian Saliba, Elisabetta Cameroni, Antonino Cassotta, Jun Siong Low, Alexandra C. Walls, Matthew McCallum, M. Alejandra Tortorici, John E. Bowen, Exequiel A. Dellota, Jr., Josh R. Dillen, Nadine Czudnochowski, Laura Pertusini, Tatiana Terrot, Valentino Lepori, Maciej Tarkowski, Agostino Riva, Maira Biggiogero, Alessandra Franzetti-Pellanda, Christian Garzoni, Paolo Ferrari, Alessandro Ceschi, Olivier Giannini, Colin Havenar-Daughton, Amalio Telenti, Ann Arvin, Herbert W. Virgin, Federica Sallusto, David Veesler, Antonio Lanzavecchia, Davide Corti, Luca Piccoli
Publikováno v:
iScience, Vol 26, Iss 1, Pp 105726- (2023)
Summary: Memory B cells (MBCs) generate rapid antibody responses upon secondary encounter with a pathogen. Here, we investigated the kinetics, avidity, and cross-reactivity of serum antibodies and MBCs in 155 SARS-CoV-2 infected and vaccinated indivi
Externí odkaz:
https://doaj.org/article/bf76fb519d3e40cd9db93e017e602507
Autor:
Lisa Perruzza, Stefano Jaconi, Gloria Lombardo, Debora Pinna, Francesco Strati, Diego Morone, Frauke Seehusen, Yue Hu, Sakshi Bajoria, Jian Xiong, Ozan Selahattin Kumru, Sangeeta Bagai Joshi, David Bernard Volkin, Renato Piantanida, Fabio Benigni, Fabio Grassi, Davide Corti, Matteo Samuele Pizzuto
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Campylobacter infection is one of the most common causes of bacterial gastroenteritis worldwide and a major global health threat due to the rapid development of antibiotic resistance. Currently, there are no vaccines approved to prevent campylobacter
Externí odkaz:
https://doaj.org/article/3421435930b0461a8648673df0393eaf
Autor:
Amin Addetia, Luca Piccoli, James Brett Case, Young-Jun Park, Martina Beltramello, Barbara Guarino, Ha Dang, Dora Pinto, Suzanne M. Scheaffer, Kaitlin Sprouse, Jessica Bassi, Chiara Silacci-Fregni, Francesco Muoio, Marco Dini, Lucia Vincenzetti, Rima Acosta, Daisy Johnson, Sambhavi Subramanian, Christian Saliba, Martina Giurdanella, Gloria Lombardo, Giada Leoni, Katja Culap, Carley McAlister, Anushka Rajesh, Exequiel Dellota, Jiayi Zhou, Nisar Farhat, Dana Bohan, Julia Noack, Florian A. Lempp, Elisabetta Cameroni, Bradley Whitener, Olivier Giannini, Alessandro Ceschi, Paolo Ferrari, Alessandra Franzetti-Pellanda, Maira Biggiogero, Christian Garzoni, Stephanie Zappi, Luca Bernasconi, Min Jeong Kim, Gretja Schnell, Nadine Czudnochowski, Nicholas Franko, Jennifer K. Logue, Courtney Yoshiyama, Cameron Stewart, Helen Chu, Michael A. Schmid, Lisa A. Purcell, Gyorgy Snell, Antonio Lanzavecchia, Michael S. Diamond, Davide Corti, David Veesler
Publikováno v:
bioRxiv
Currently circulating SARS-CoV-2 variants acquired convergent mutations at receptor-binding domain (RBD) hot spots1. Their impact on viral infection, transmission, and efficacy of vaccines and therapeutics remains poorly understood. Here, we demonstr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce29f8388403bbef8bf55f16166bdbea
https://europepmc.org/articles/PMC9882201/
https://europepmc.org/articles/PMC9882201/
Autor:
Roberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, Istvan Bartha, Francesco Muoio, Katja Culap, Nicole Sprugasci, Gloria Lombardo, Christian Saliba, Elisabetta Cameroni, Antonino Cassotta, Jun Siong Low, Alexandra C. Walls, Matthew McCallum, M. Alejandra Tortorici, John E. Bowen, Exequiel A. Dellota, Josh R. Dillen, Nadine Czudnochowski, Laura Pertusini, Tatiana Terrot, Valentino Lepori, Maciej Tarkowski, Agostino Riva, Maira Biggiogero, Alessandra Franzetti Pellanda, Christian Garzoni, Paolo Ferrari, Alessandro Ceschi, Olivier Giannini, Colin Havenar-Daughton, Amalio Telenti, Ann Arvin, Herbert W. Virgin, Federica Sallusto, David Veesler, Antonio Lanzavecchia, Davide Corti, Luca Piccoli
Publikováno v:
bioRxiv
iScience, 26 (1)
iScience, 26 (1)
Memory B cells (MBCs) generate rapid antibody responses upon secondary encounter with a pathogen. Here, we investigated the kinetics, avidity, and cross-reactivity of serum antibodies and MBCs in 155 SARS-CoV-2 infected and vaccinated individuals ove
Autor:
Florian A. Lempp, Tassilo Volz, Elisabetta Cameroni, Fabio Benigni, Jiayi Zhou, Laura E. Rosen, Julia Noack, Fabrizia Zatta, Hannah Kaiser, Siro Bianchi, Gloria Lombardo, Stefano Jaconi, Hasan Imam, Leah B. Soriaga, Nadia Passini, David M. Belnap, Andreas Schulze, Marc Lütgehetmann, Amalio Telenti, Andrea L. Cathcart, Gyorgy Snell, Lisa A. Purcell, Christy M. Hebner, Stephan Urban, Maura Dandri, Davide Corti, Michael A. Schmid
Background & AimsChronic hepatitis B is a major global public health problem, and coinfection with hepatitis delta virus (HDV) worsens disease outcome. Here, we describe a hepatitis B virus (HBV) surface antigen (HBsAg)-targeting monoclonal antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6fec46ca7004efc0b3dbdb32e584ca22
https://doi.org/10.1101/2022.09.09.507326
https://doi.org/10.1101/2022.09.09.507326
Autor:
Jason A. Wojcechowskyj, Marcel Meury, Dora Pinto, Exequiel Dellota, Fabio Benigni, Jesse D. Bloom, M. Alejandra Tortorici, Florian A. Lempp, Anna De Marco, Josh Dillen, Christy M. Hebner, Amin Addetia, Fabrizia Zatta, Laura E. Rosen, Elisabetta Cameroni, Nadine Czudnochowski, Amalio Telenti, Johan Neyts, Stefano Jaconi, Allison J. Greaney, Zhuoming Liu, Patrick Hernandez, John E. Bowen, Roberta Marzi, Jiayi Zhou, Maria L. Agostini, Hannah Kaiser, William G. Glass, Rana Abdelnabi, Ivy Zhang, Tristan I. Croll, Adam S. Dingens, Gyorgy Snell, Shi-Yan Caroline Foo, Davide Corti, Luca Piccoli, Martin Montiel-Ruiz, David Veesler, Sean P. J. Whelan, Gloria Lombardo, Herbert W. Virgin, Martina Beltramello, Colin Havenar-Daughton, Spencer Stumpf, Tyler N. Starr, Michael P. Housley, Jessica Bassi, John D. Chodera, Katja Culap, Nicole Sprugasci, Julia di Iulio, Chiara Silacci-Fregni, Matteo Samuele Pizzuto, Alexandra C. Walls, Young-Jun Park, Jay C. Nix, Heather Tucker
Publikováno v:
Nature
Nature, vol 597, iss 7874
Nature, vol 597, iss 7874
An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1–3, have activity against diverse sarbecoviruses4–7, and be highly protective through viral neutralization8–11 and effector functions12,13. Understanding how these properti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea33aa8d0b103b0c5bd075c01c53fa5a
https://europepmc.org/articles/PMC9282883/
https://europepmc.org/articles/PMC9282883/
Autor:
Gloria Lombardo, Jian Xiong, Yue Hu, Matteo Samuele Pizzuto, Diego Morone, Renato Piantanida, Stefano Jaconi, Ozan S. Kumru, Davide Corti, Lisa Perruzza, Sangeeta B. Joshi, David B. Volkin, Fabio Grassi, Sakshi Bajoria, Debora Pinna, Francesco Strati, Fabio Benigni, Frauke Seehusen
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology, Vol 11 (2020)
Campylobacter infection is one of the most common causes of bacterial gastroenteritis worldwide and a major global health threat due to the rapid development of antibiotic resistance. Currently, there are no vaccines approved to prevent campylobacter